Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Clinical Application of wIRA Irradiation in Burn Wounds

Bingoel AS., Strauss S., Vogt PM.

Narrative Review on Chronic Wound, Burns, published in (2022) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
(2022)
Reported sample size
—
Source database
Europe PMC
PMID
37494528

Abstract (original English)

Besides operative procedures (e.g., necrosectomies, skin grafting), conservative treatments of thermal injuries are increasingly important. wIRA as an additional therapy for burns, scalds, and chemically induced injuries and for treating severe skin reactions (e.g., toxic epidermal necrolysis) is used in our clinic on a daily basis. The most successful therapy involves 3–4 irradiations/30 min/day. Therefore, patients with superficial partial-thickness burns are treated with topical polyhexanide ointment and wIRA 2–4 days after the accident. In these cases, we see a quick wound-drying and a rapid re-epithelialization of the skin. The approach in deep partial-thickness burns depends on whether surgical procedures must be postponed due to poor general conditions. In these patients, preservation of the wound perfusion in regions that are not fully damaged is intended, avoiding extensive necrosectomies. Although third-degree burns are dry and do not require wIRA irradiation, it can be used for adjacent regions with minor degree burns. Preliminary in vitro data suggest a wIRA-induced migration of adipose-derived stem cells. Postoperatively, wIRA is used on areas transplanted with split-thickness skin grafts. After removal of the tie-over bolsters, wIRA is applied 3–4 times/20–30 min/day. The grafts exhibit a faster epithelialization of the fenestrated spots, and postoperative infecti

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research